Back Home >> CLRB
Added on - 12/21/2020
| Symbol | L / S | Swing | Alarm Price | Sector | Volume | 60 Day Volume | Earnings Date |
|---|---|---|---|---|---|---|---|
| CLRB | Long | No | Healthcare | 0K | 3.5Mil | N/A |
Update Required
To play the media you will need to either update your browser to a recent version or update your Flash plugin.
Yahoo News
- Cellectar Biosciences, Inc. (NASDAQ:CLRB): When Will It Breakeven?
- Cellectar Biosciences, Inc. (NASDAQ:CLRB) Q4 2023 Earnings Call Transcript
- Q4 2023 Cellectar Biosciences Inc Earnings Call
- Cellectar Biosciences Reports Financial Results for Year Ended 2023 and Provides a Corporate Update
- Cellectar Biosciences to Announce 2023 Year End Earnings Results and Host a Conference Call on Wednesday, March 27, 2024
- Cellectar Biosciences to Present at the 36th Annual Roth Conference
- Cellectar Biosciences Reports High Rate of Complete Remission in Investigator Initiated Phase I Study of Iopofosine in Combination with External Beam Radiotherapy in Recurrent Head and Neck Cancer
- Cellectar Biosciences to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference
- Cellectar Biosciences Announces Enrollment of the First Patient in Pediatric High-Grade Gliomas Phase 1b Clinical Study
Seeking Alpha News
- Cellectar Biosciences, Inc. (CLRB) Q4 2023 Earnings Call Transcript
- AstraZeneca-Fusion deal reignites radiopharma space
- Radiopharmaceutical market expected to reach ~$14B by 2032
- Cellectar Biosciences: A Shoestring Opportunity You're About To Miss
- Cellectar stock climbs 8% on results for CNS malignancy therapy